BetterWay and University of Texas to Collaborate on Brain Health Capillary BiomarkersAUSTIN, TX / ACCESS Newswire / September 24, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a three-year research collaboration agreement with The University of Texas at Austin to study brain health biomarkers in capillary blood.
BetterWay(TM) Blood Testing Shows How U.S. Logistics Can Help Expand Access to Healthcare at Made in America SummitPairing sophisticated logistics with patient-friendly fingertip collection without phlebotomists could reduce non-adherence to routine testing
